A model of sustainable drug development: recycling old drugs to turn them into long term anti-cancer targeted therapies Drug repositioning consists in using old drugs for new indications. The theoretical and pragmatic advantages to testing already established drugs for a potential effect on cancer cells are clear. The side-effects are known and have already been well documented. Phase I are not mandatory so that, those drugs can immediately enter phase II studies to test their efficacy for (...)